Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Dawn Aubel"'
Autor:
Lara Rodríguez-Laguna, Kristen Davis, Mellenee Finger, Dawn Aubel, Robin Vlamis, Craig Johnson
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 17, Iss 1, Pp 1-12 (2022)
Abstract Background PROS disorders are driven by somatic, gain-of-function mutations in PIK3CA that result in hyperactivation of the phosphatidylinositol-3-kinase (PI3K) signaling pathway. PROS encompasses a broad spectrum of overlapping phenotypes (
Externí odkaz:
https://doaj.org/article/340ef9c9e2884402a61ae9466d67dc8e
Autor:
Lesley Fallowfield, Frances M. Boyle, Luzia Travado, Belinda E. Kiely, Patti Jewell, Dawn Aubel, Fatima Cardoso
Publikováno v:
JCO Global Oncology, Vol , Iss 7, Pp 976-984 (2021)
PURPOSEAlthough new therapeutic options continue to improve disease-related outcomes in advanced breast cancer (ABC), enhanced focus is needed to improve quality of life for patients currently living with ABC.METHODSIn November 2019, a multidisciplin
Externí odkaz:
https://doaj.org/article/ffa4044c02094a57aad6b1f0f41fc087
Publikováno v:
Cancer Research. 81:PS9-16
Background. There is currently no cure for advanced breast cancer (ABC) and patients living with the disease are faced with many challenges influencing their ability to work and carry out daily tasks. ABC also imposes significant direct and indirect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ef71af1c63087512ab9e7e26be57616e
https://doi.org/10.1158/1538-7445.sabcs20-ps9-16
https://doi.org/10.1158/1538-7445.sabcs20-ps9-16
Autor:
Lara Rodríguez-Laguna, Kristen Davis, Mellenee Finger, Dawn Aubel, Robin Vlamis, Craig Johnson
Publikováno v:
Orphanet journal of rare diseases. 17(1)
Background PROS disorders are driven by somatic, gain-of-function mutations in PIK3CA that result in hyperactivation of the phosphatidylinositol-3-kinase (PI3K) signaling pathway. PROS encompasses a broad spectrum of overlapping phenotypes (including
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f00b1323bf3d546d8b2c1782f19d262
https://pubmed.ncbi.nlm.nih.gov/35526022
https://pubmed.ncbi.nlm.nih.gov/35526022
Autor:
Luzia Travado, Frances M. Boyle, Lesley Fallowfield, Fatima Cardoso, Patti Jewell, Dawn Aubel, Belinda E Kiely
Publikováno v:
JCO Global Oncology
PURPOSE Although new therapeutic options continue to improve disease-related outcomes in advanced breast cancer (ABC), enhanced focus is needed to improve quality of life for patients currently living with ABC. METHODS In November 2019, a multidiscip
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e7ad4830a5e3c29aaa99c1e1b56294f
Autor:
Dawn Aubel
Publikováno v:
Supportive Care in Cancer
Purpose The aim of this study was to investigate the perceptions of cancer survivors who continue to work and provide information to evaluate and develop a supportive workplace program (Ensemble) based on the principles of navigation. Methods A mixed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dee56888202b68f59f8c8a663f501580
http://europepmc.org/articles/PMC6803589
http://europepmc.org/articles/PMC6803589
Publikováno v:
The Breast. 59:S39
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6c61db81c7c06cdfd1a5a5c1a5995336
https://doi.org/10.1016/s0960-9776(21)00525-7
https://doi.org/10.1016/s0960-9776(21)00525-7
Autor:
Yeon Hee Park, Ines Lorenzo, Sibylle Loibl, Pamela Drullinsky, Dawn Aubel, Ginny Mason, Hope S. Rugo, Fabrice Andre, Eva Ciruelos, Fatima Cardoso, Murat Akdere
Publikováno v:
The Breast. 59:S49
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aaf9b1de31def260393f8d52349ee51a
https://doi.org/10.1016/s0960-9776(21)00547-6
https://doi.org/10.1016/s0960-9776(21)00547-6
Autor:
Cassandra Slader, Dexter Patel, Chandra Rekha Gulabani, JungHo Park, Noha Mohamed Mahmoud Abdelbaky, Rami El Sayegh, Julie Rihani, Dawn Aubel, Michaela Dinboeck
Publikováno v:
Journal of Clinical Oncology. 39:e18519-e18519
e18519 Background: Incorporating patient (pt) perspectives in the development of new therapies (from trial design to regulatory & reimbursement decisions) and providing pts with plain language summaries (PLS) of clinical trial results is increasingly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::330a028a5eee7a597f2114a226c64036
https://doi.org/10.1200/jco.2021.39.15_suppl.e18519
https://doi.org/10.1200/jco.2021.39.15_suppl.e18519
Autor:
Alexey Salamakha, Ginny Mason, Andrew Ciupek, Dawn Aubel, Geoffrey Cook, Susan Hayes, Gunjan Patel
Publikováno v:
Journal of Clinical Oncology. 38:e14084-e14084
e14084 Background: Evidence-based guidance on how to best facilitate patient engagement in the drug development process is lacking1,2.Well-informed, engaged patients and advocates can contribute meaningfully throughout drug development process for ne
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ed0a9443e0979858c87731d23e99936a
https://doi.org/10.1200/jco.2020.38.15_suppl.e14084
https://doi.org/10.1200/jco.2020.38.15_suppl.e14084